56Indexed trials
Market Rank #49 · Evidence Tier A
Puerto Rico
Neuroscience Intelligence
Puerto Rico neuroscience intelligence: 56 indexed trials, 8 institutions, research score 26.76.
14Recruiting
8Research institutions
26.8Research score
Evidence profile
30Sponsors
16Disease areas
0Institution works
0Institution citations
Evidence signals
Research score 26.8 · Data confidence 100.00 · Evidence 26.8
Data confidence measures presence of evidence layers, not a probability of success. Scores are comparative decision-support signals, not guaranteed market size or commercial outcomes.
Leading disease areas
alzheimers14trials
pain_neuropathy6trials
epilepsy5trials
multiple_sclerosis5trials
parkinsons4trials
schizophrenia3trials
migraine_headache3trials
stroke2trials
als2trials
autism2trials
Leading indexed sponsors
Eli Lilly and Company8trials
AbbVie4trials
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.4trials
Pfizer3trials
GlaxoSmithKline3trials
Novartis Pharmaceuticals3trials
Kodiak Sciences Inc2trials
Axsome Therapeutics, Inc.2trials
Merck Sharp & Dohme LLC2trials
Hoffmann-La Roche2trials